-
The double-edge sword of stress
09 November 2022
Finding balance in a stressful world isn't easy - but here are some ways to make it easier
-
Pandemic-induced emotional trauma — a lasting legacy for ourselves and our children?
05 August 2020
Join Meleni Aldridge and certified functional medicine practitioner, Leonie Ash, discussing how stress and trauma become silent health assasins and how to recognise and undo the effects
-
Control Group Cooperative survey findings published!
24 August 2022
After significant censorship, the preprint paper we released in June is now in print in revised form in an uncensored peer reviewed journal
News / ANH Covid Zone / Health / Campaigns / Research
-
Alzheimer’s disease: cheap nutrients outperform latest drug
05 October 2022
Acclaimed nutritionist Patrick Holford speaks to ANH Founder Rob Verkerk PhD about the Food for the Brain Foundation’s launch of the ‘Alzheimer’s is Preventable’ campaign
-
Natural News Roundup (week 33/2022)
17 August 2022
Ranking healthfulness of foods; Exercise needed to lose weight; Gene editing risks; Eco-labels for food; Vitamin D beats depression; Scientists question climate emergency
-
News Alerts: Week 36, 2020
02 September 2020
Citizens protest covid restrictions; Soup & shake diet to combat diabetes; The case for Vitamin C; Social isolation causes brain damage; Celebrities mask promotion; Health Passport Ireland; Plain English 5G
-
Learning how to communicate covid science effectively
01 July 2022
Rob Verkerk PhD in conversation with behaviour and communications expert David Charalambous
News / ANH Covid Zone / Health / Campaigns / Education
-
Covid News Unwrapped (week 41/2022)
12 October 2022
Our curated roundup of global covid news and information continues as we document the effects of the coronavirus crisis and its ongoing legacy
News / ANH Covid Zone / Health / Campaigns
-
News Alerts: Week 40, 2020
01 October 2020
UK Parliament renews Coronavirus Act; Boris challenged to covid science debate; Covid natural health study; American’s suffer low resilience; Sir Lloyd-Webber joins vaccine trial; CBD studies